Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA4 | P22748 | 3/20 | 0.41 |
| ▸ | CA7 | P43166 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.40 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalic Acid SCHEMBL2171614 | 0.79 | ALDH1A1 (0.64) | ALDH1A1ALOX15MAPTHDAC8CA12 | |
| SCHEMBL934414 | 0.79 | — | — | |
| Phthalic Acid SCHEMBL27101379 | 0.77 | ALDH1A1 (0.61) | ALDH1A1ALOX15MAPTHDAC8CA12 | |
| Phthalic Acid SCHEMBL28052464 | 0.77 | ALDH1A1 (0.74) | ALDH1A1ALOX15MAPTHDAC8CA12 | |
| Phthalic Acid SCHEMBL30100313 | 0.77 | ALDH1A1 (0.82) | ALDH1A1ALOX15MAPTHDAC8CA12 | |
| Phthalic Acid SCHEMBL8398555 | 0.77 | ALDH1A1 (0.82) | ALDH1A1ALOX15MAPTHDAC8CA12 | |
| Phthalic Acid SCHEMBL2561870 | 0.77 | ALDH1A1 (0.82) | ALDH1A1ALOX15MAPTHDAC8CA12 | |
| Phthalic Acid SCHEMBL7897915 | 0.77 | ALDH1A1 (0.82) | ALDH1A1ALOX15MAPTHDAC8CA12 | |
| Phthalic Acid SCHEMBL2777 | 0.77 | ALDH1A1 (0.82) | ALDH1A1ALOX15MAPTHDAC8CA12 | |
| Phthalic Acid SCHEMBL29358471 | 0.77 | ALDH1A1 (0.82) | ALDH1A1ALOX15MAPTHDAC8CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230058942-A1 | EXTENDED RELEASE MULTIPARTICULATES OF RANOLAZINE | SUN PHARMACEUTICAL IND LTD (IN) | 2023-02-23 | — | — | US | claimed |
| US-20210228488-A1 | EXTENDED RELEASE COMPOSITIONS AND PROCESS FOR PREPARATION | RUBICON RES PRIVATE LIMITED (IN) | 2021-07-29 | — | — | US | claimed |
| US-20210106537-A1 | EXTENDED RELEASE MULTIPARTICULATES OF RANOLAZINE | SUN PHARMACEUTICAL IND LTD (IN) | 2021-04-15 | — | — | US | claimed |
| US-10898444-B2 | Extended release multiparticulates of ranolazine | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2021-01-26 | — | — | US | claimed |
| EP-1898886-B1 | NOVEL SUSTAINED RELEASE DOSAGE FORM | RUBICON RES PVT LTD (IN) | 2019-09-04 | — | — | EP | claimed |
| US-20190262268-A1 | ORAL MODIFIED RELEASE FORMULATIONS | RUBICON RES PRIVATE LIMITED (IN) | 2019-08-29 | — | — | US | claimed |
| US-20180344653-A1 | EXTENDED RELEASE MULTIPARTICULATES OF RANOLAZINE | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2018-12-06 | — | — | US | claimed |
| EP-3409273-A1 | EXTENDED RELEASE MULTIPARTICULATES OF RANOLAZINE | Sun Pharmaceutical Industries Limited (IN) | 2018-12-05 | — | — | EP | claimed |
| WO-2018055641-A1 | ORAL MODIFIED RELEASE FORMULATIONS | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2018-03-29 | — | — | WO | claimed |
| US-20160220512-A1 | MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS | RUBICON RES PRIVATE LTD (IN) | 2016-08-04 | — | — | US | claimed |
| US-20100047341-A1 | COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY | HANALL PHARMACEUTICAL CO., LTD. (KR) | 2010-02-25 | — | — | US | claimed |
| EP-2079451-A1 | COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY | Hanall Pharmaceutical Co., Ltd. (KR) | 2009-07-22 | — | — | EP | claimed |
| WO-2009078034-A2 | ORAL DISINTEGRATING TABLETS OF ROPINIROLE HYDROCHLORIDE | RUBICON RESEARCH PRIVATE LIMITED (IN) | 2009-06-25 | — | — | WO | claimed |
| WO-2008044862-A1 | COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY | HANALL PHARMACEUTICAL CO., LTD. (KR) | 2008-04-17 | — | — | WO | claimed |
| EP-1101490-B1 | PREPARATION CAPABLE OF RELEASING DRUG AT TARGET SITE IN INTESTINE | TANABE SEIYAKU CO (JP) | 2005-04-13 | — | — | EP | claimed |
| US-6638534-B1 | High speed release; coating of acrylic, maleic or polyvinyl polymer; inflammable bowel syndrome, Crohn*s disease | TANABE SEIYAKU CO., LTD. (JP) | 2003-10-28 | — | — | US | claimed |
| EP-1101490-A1 | PREPARATION CAPABLE OF RELEASING DRUG AT TARGET SITE IN INTESTINE | TANABE SEIYAKU CO., LTD. (JP) | 2001-05-23 | — | — | EP | claimed |
| EP-0122815-B1 | ENTERIC-SOLUBLE PREPARATIONS AND A PROCESS FOR THEIR PRODUCTION | SANKYO COMPANY LIMITED (JP) | 1989-10-25 | — | — | EP | claimed |
| US-4661162-A | MIXTURE OF POLYMER WITH POLYANIONIC POLYMER WHICH IS SOLUBLE AT LOW PH | SANKYO COMPANY, LIMITED (JP) | 1987-04-28 | — | — | US | claimed |
| EP-0122815-A1 | Enteric-soluble preparations and a process for their production | SANKYO COMPANY LIMITED (JP) | 1984-10-24 | — | — | EP | claimed |